Joint Task Force guidelines recommend managing contact dermatitis by identifying and avoiding triggers and treatment with hydrocortisone 1% cream. Use emollients like petroleum jelly or ceramide-based creams to repair the skin barrier, and consider calamine lotion or colloidal oatmeal baths for additional symptom relief. For severe or widespread cases, systemic corticosteroids or prescription topical calcineurin inhibitors may be necessary.
January 11, 2025

Contact Dermatitis: Joint Task Force Guidelines

Evidence-Based Over-the-Counter Guide

William Shen

William Shen

Co-founder & CPO

See all guides. Have more questions?

This guide is based on the Joint Task Force Practice Parameter for Contact Dermatitis–Update 2015.

At least 1 in 5 of the general population (more frequently in women then men) are contact-allergic to common environmental allergens. Contact dermatitis is an inflammatory skin reaction caused by exposure to irritants or allergens. Treatment focuses on symptom relief and avoiding triggers.

Characteristics specific to contact dermatitis include: 

  • Glazed, parched, or scalded appearance

  • Sharply circumscribed dermatitis

  • Healing begins promptly on withdrawal of the offending agent

Industries and jobs that pose a high risk for development of occupational contact dermatitis are as follows:

  1. Food service and food processing (cooks and caterers)

  2. Cosmetology (beauticians and hairdressers)

  3. Health care (personnel)

  4. Agriculture, forestry, and fishing

  5. Cleaning

  6. Painting

  7. Mechanics, metal working, and vehicle assembly

  8. Electronics industry

  9. Printing and/or lithography

  10. Construction

First-line recommendations: 

  • Trigger identification: Identification and avoidance of contact with the offending agent(s) is the key to successful treatment. Review any recent abnormal exposures, new lotions, garments, foods, furniture, etc. 

  • Topical corticosteroids: Reduce inflammation and itching. Hydrocortisone 1% cream (FDA M017): Apply thinly to affected areas 1-2 times daily for up to 7 days.

Second-line recommendations: 

Prevention:

  • Reducing exposure: If irritant is related to job or other necessary task, examples of methods of reducing exposure include using long handled cleaning tools (brush with a handle), vacuuming, or wet sweeping

Prescription medications:

  • Systemic corticosteroids: For widespread or severe cases (e.g., prednisone).

  • Topical calcineurin inhibitors: For sensitive areas like the face.

Citations:

Fonacier L, Bernstein DI, Pacheco K, et al. Contact Dermatitis: A Practice Parameter–Update 2015. The Journal of Allergy and Clinical Immunology: In Practice. 2015; 3(3): p.S1-S39. doi: 10.1016/j.jaip.2015.02.009

Alinaghi, F., Bennike, N. H., Egeberg, A., Thyssen, J. P., & Johansen, J. D. (2019). Prevalence of contact allergy in the general population: a systematic review and meta‐analysis. Contact dermatitis, 80(2), 77-85.

What OTC evidence is reviewed?

  • For each condition, we performed a literature review to find a recent widely cited expert group guideline published in the leading specialty-specific peer-reviewed journal or top general medical journal.

  • Based on the recommendations in the publication, we identify recommended active ingredients and devices that are available over-the-counter per FDA regulations.

What evidence is prioritized?

Levels of evidence considered:

  • Tier 1 (Safe and Definitely Effective): Professional field consensus or multiple randomized controlled clinical trials showing the same conclusion. Wherever possible, we use Tier 1 evidence for "first-line" recommendations.

  • Tier 2 (Safe and Probably Effective): Individual clinical trials which may be discordant or large-scale observational experience. Tier 2 evidence may inform "first-line", "second-line", or "supplement" recommendations.

  • Tier 3 (Safe and Maybe Effective): Mechanistic plausibility without high-quality clinical evidence of efficacy but high-quality evidence of safety. Tier 3 evidence may inform "second-line" or "supplement" recommendations.

How does MDandMe select recommended products?

  • Based on the top clinical recommendation, we evaluate products containing the recommended active agent with FDA-approved dosage based on price, average customer reviews, how often it is purchased, and how quickly it will ship to home. 

  • We provide public documentation of the active ingredients in our recommendations, using all 32 FDA monographs, Prescription-to-Nonprescription (Rx-to-OTC) Switches, as well as New Drug Application (NDA) approvals.

How does MDandMe select recommended devices?

  • Based on the top clinical recommendation, we evaluate devices that are FDA-cleared or comply with other medical guidelines (if not a FDA-regulated category) by reputability, price, and average customer reviews.

  • We provide public documentation of supporting evidence for each device.